Interleukin-3 administration enhances human monocyte function in vivo

Br J Haematol. 1994 Nov;88(3):515-9. doi: 10.1111/j.1365-2141.1994.tb05067.x.

Abstract

In addition to its haemopoietic effects, interleukin-3 (IL-3) enhances leucocyte function in vitro. In this study we examined the effects on haematological variables and monocyte function of a single IL-3 infusion in five haematologically normal individuals. There was a rapid fall in circulating monocyte (to 24 +/- 6% of pre-infusion value) and eosinophil numbers (to 3 +/- 2%) with a nadir at 30 min and gradual return to baseline over 6 h. No significant changes in monocyte expression of the adhesion molecules CD11b or L-selectin or of monocyte respiratory burst activity were detected. There was a significant increase in monocyte phagocytosis and killing of Candida after IL-3 infusion: the percentage of monocytes which had ingested Candida increased from 39 +/- 10% to 62 +/- 12% and the total number of Candida killed per 100 monocytes increased from 63 +/- 34 to 210 +/- 59 (P < 0.05 and P < 0.01 respectively). There was no inhibition of neutrophil migration into a 'skin window' site and monocyte migration was moderately enhanced (peak increase of 260 +/- 47%). These results show that IL-3 has significant effects on monocyte function in vivo and could be of use in augmenting host defence mechanisms in immunocompromised patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD11 Antigens / metabolism
  • Cell Adhesion Molecules / metabolism
  • Cell Movement
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Interleukin-3 / pharmacokinetics
  • Interleukin-3 / pharmacology*
  • L-Selectin
  • Leukocyte Count
  • Monocytes / metabolism
  • Monocytes / physiology*
  • Neutrophils / metabolism
  • Phagocytosis
  • Respiratory Burst

Substances

  • CD11 Antigens
  • Cell Adhesion Molecules
  • Interleukin-3
  • L-Selectin